Publication | Closed Access
A phase I/II study of docetaxel in combination with pegylated liposomal doxorubicin in metastatic castration-resistant prostate cancer
12
Citations
19
References
2020
Year
Pegylated Liposomal DoxorubicinUrologyOncologyPhase I/ii StudyMedicinePolymer-drug ConjugatePharmacotherapyAnti-cancer AgentCancer TreatmentProstatic DiseasePharmacologyDrug Discovery
| Year | Citations | |
|---|---|---|
Page 1
Page 1